Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a non-blinded phase 2 trial in Stage II-IIIa urothelial cancer randomizing pre-operative nivolumab with or without relatlimab to assess whether bladder preservation after dual immunotherapy would be a viable treatment option for patients responding to treatment
Epistemonikos ID: b293adeeae4e7760bc66e3da71fb428196f72084
First added on: May 15, 2024